BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 10196284)

  • 1. Ikappakappa mediates NF-kappaB activation in human immunodeficiency virus-infected cells.
    Asin S; Taylor JA; Trushin S; Bren G; Paya CV
    J Virol; 1999 May; 73(5):3893-903. PubMed ID: 10196284
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic human immunodeficiency virus type 1 infection of myeloid cells disrupts the autoregulatory control of the NF-kappaB/Rel pathway via enhanced IkappaBalpha degradation.
    DeLuca C; Roulston A; Koromilas A; Wainberg MA; Hiscott J
    J Virol; 1996 Aug; 70(8):5183-93. PubMed ID: 8764027
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nuclear IkappaBbeta maintains persistent NF-kappaB activation in HIV-1-infected myeloid cells.
    DeLuca C; Petropoulos L; Zmeureanu D; Hiscott J
    J Biol Chem; 1999 May; 274(19):13010-6. PubMed ID: 10224051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Ras-Raf pathway is activated in human immunodeficiency virus-infected monocytes and particpates in the activation of NF-kappa B.
    Folgueira L; Algeciras A; MacMorran WS; Bren GD; Paya CV
    J Virol; 1996 Apr; 70(4):2332-8. PubMed ID: 8642660
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inducible expression of IkappaBalpha repressor mutants interferes with NF-kappaB activity and HIV-1 replication in Jurkat T cells.
    Kwon H; Pelletier N; DeLuca C; Genin P; Cisternas S; Lin R; Wainberg MA; Hiscott J
    J Biol Chem; 1998 Mar; 273(13):7431-40. PubMed ID: 9516441
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phosphorylation of IkappaBalpha in the C-terminal PEST domain by casein kinase II affects intrinsic protein stability.
    Lin R; Beauparlant P; Makris C; Meloche S; Hiscott J
    Mol Cell Biol; 1996 Apr; 16(4):1401-9. PubMed ID: 8657113
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synergistic activation of human immunodeficiency virus type 1 promoter activity by NF-kappaB and inhibitors of deacetylases: potential perspectives for the development of therapeutic strategies.
    Quivy V; Adam E; Collette Y; Demonte D; Chariot A; Vanhulle C; Berkhout B; Castellano R; de Launoit Y; Burny A; Piette J; Bours V; Van Lint C
    J Virol; 2002 Nov; 76(21):11091-103. PubMed ID: 12368351
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The human immunodeficiency virus type 1 Vpu protein inhibits NF-kappa B activation by interfering with beta TrCP-mediated degradation of Ikappa B.
    Bour S; Perrin C; Akari H; Strebel K
    J Biol Chem; 2001 May; 276(19):15920-8. PubMed ID: 11278695
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transdominant mutants of I kappa B alpha block Tat-tumor necrosis factor synergistic activation of human immunodeficiency virus type 1 gene expression and virus multiplication.
    Beauparlant P; Kwon H; Clarke M; Lin R; Sonenberg N; Wainberg M; Hiscott J
    J Virol; 1996 Sep; 70(9):5777-85. PubMed ID: 8709193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distinct domains of IkappaB-alpha inhibit human immunodeficiency virus type 1 replication through NF-kappaB and Rev.
    Wu BY; Woffendin C; MacLachlan I; Nabel GJ
    J Virol; 1997 Apr; 71(4):3161-7. PubMed ID: 9060679
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of HIV-1 long terminal repeat transcription and virus replication via NF-kappaB-dependent and -independent pathways by potent phosphotyrosine phosphatase inhibitors, the peroxovanadium compounds.
    Barbeau B; Bernier R; Dumais N; Briand G; Olivier M; Faure R; Posner BI; Tremblay M
    J Biol Chem; 1997 May; 272(20):12968-77. PubMed ID: 9148903
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Signal transduction pathways triggered by the FcepsilonRIIb receptor (CD23) in human monocytes lead to nuclear factor-kappaB activation.
    Ten RM; McKinstry MJ; Bren GD; Paya CV
    J Allergy Clin Immunol; 1999 Aug; 104(2 Pt 1):376-87. PubMed ID: 10452760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Caspase-3-mediated cleavage of p65/RelA results in a carboxy-terminal fragment that inhibits IkappaBalpha and enhances HIV-1 replication in human T lymphocytes.
    Coiras M; López-Huertas MR; Mateos E; Alcamí J
    Retrovirology; 2008 Dec; 5():109. PubMed ID: 19046417
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Permanent occupancy of the human immunodeficiency virus type 1 enhancer by NF-kappa B is needed for persistent viral replication in monocytes.
    Jacqué JM; Fernández B; Arenzana-Seisdedos F; Thomas D; Baleux F; Virelizier JL; Bachelerie F
    J Virol; 1996 May; 70(5):2930-8. PubMed ID: 8627768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ursolic acid inhibits nuclear factor-kappaB activation induced by carcinogenic agents through suppression of IkappaBalpha kinase and p65 phosphorylation: correlation with down-regulation of cyclooxygenase 2, matrix metalloproteinase 9, and cyclin D1.
    Shishodia S; Majumdar S; Banerjee S; Aggarwal BB
    Cancer Res; 2003 Aug; 63(15):4375-83. PubMed ID: 12907607
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NF-kappaB activation during Rickettsia rickettsii infection of endothelial cells involves the activation of catalytic IkappaB kinases IKKalpha and IKKbeta and phosphorylation-proteolysis of the inhibitor protein IkappaBalpha.
    Clifton DR; Rydkina E; Freeman RS; Sahni SK
    Infect Immun; 2005 Jan; 73(1):155-65. PubMed ID: 15618150
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Arsenic inhibits NF-kappaB-mediated gene transcription by blocking IkappaB kinase activity and IkappaBalpha phosphorylation and degradation.
    Roussel RR; Barchowsky A
    Arch Biochem Biophys; 2000 May; 377(1):204-12. PubMed ID: 10775461
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CpG stimulation of primary mouse B cells is blocked by inhibitory oligodeoxyribonucleotides at a site proximal to NF-kappaB activation.
    Lenert P; Stunz L; YI AK; Krieg AM; Ashman RF
    Antisense Nucleic Acid Drug Dev; 2001 Aug; 11(4):247-56. PubMed ID: 11572601
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppression of constitutive and tumor necrosis factor alpha-induced nuclear factor (NF)-kappaB activation and induction of apoptosis by apigenin in human prostate carcinoma PC-3 cells: correlation with down-regulation of NF-kappaB-responsive genes.
    Shukla S; Gupta S
    Clin Cancer Res; 2004 May; 10(9):3169-78. PubMed ID: 15131058
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NF-kappaB is involved in the survival of cerebellar granule neurons: association of IkappaBbeta [correction of Ikappabeta] phosphorylation with cell survival.
    Koulich E; Nguyen T; Johnson K; Giardina C; D'mello S
    J Neurochem; 2001 Feb; 76(4):1188-98. PubMed ID: 11181838
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.